Your Advocates Ltd’s Cytosorbents Corp CTSO Stock Holding History

Your Advocates Ltd’s Portfolio CTSO Stock Details CTSO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-250	Closed	-$143	–	216
2026 Q1	$143	Hold	250	–	–	﹤0.01%	216
2025 Q4	$160	Hold	250	–	–	﹤0.01%	220
2025 Q3	$233	Hold	250	–	–	﹤0.01%	203
2025 Q2	$320	Hold	250	–	–	﹤0.01%	182
2025 Q1	$250	Hold	250	–	–	﹤0.01%	191
2024 Q4	$228	Hold	250	–	–	﹤0.01%	194
2024 Q3	$375	Hold	250	–	–	﹤0.01%	210
2024 Q2	$175	Hold	250	–	–	﹤0.01%	219
2024 Q1	$238	Hold	250	–	–	﹤0.01%	213
2023 Q4	$278	Hold	250	–	–	﹤0.01%	218
2023 Q3	$470	Hold	250	–	–	﹤0.01%	244
2023 Q2	$898	Hold	250	–	–	﹤0.01%	238
2023 Q1	$843	Hold	250	–	–	﹤0.01%	204
2022 Q4	$388	Hold	250	–	–	﹤0.01%	202
2022 Q3	$0	Hold	250	–	–	﹤0.01%	204
2022 Q2	$1K	Hold	250	–	–	﹤0.01%	180
2022 Q1	$1K	Hold	250	–	–	﹤0.01%	200
2021 Q4	$1K	Hold	250	–	–	﹤0.01%	186
2021 Q3	$2K	Hold	250	–	–	﹤0.01%	166
2021 Q2	$2K	Hold	250	–	–	﹤0.01%	124
2021 Q1	$2K	Buy	+250	New	+$2.38K	﹤0.01%	121

Other funds holding CTSO

Avenir Corporation Alexandria, Virginia $821M AUM 4.23% 1-Year Est. Return

Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

CM Management Gulf Breeze, Florida $157M AUM 60.08% 1-Year Est. Return

Skylands Capital Milwaukee, Wisconsin $814M AUM 32.37% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

SIG

Sargent Investment Group Bethesda, Maryland $832M AUM 24.89% 1-Year Est. Return

Pathstone Holdings Englewood, New Jersey $34.3B AUM 27.35% 1-Year Est. Return

Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

Your Advocates Ltd's CTSO Position: Q2 2026 in Review

Your Advocates Ltd sold out of Cytosorbents Corp (CTSO) in Q2 2026, closing a stake of 250 shares — an estimated $143 sold.

Your Advocates Ltd first reported a position in CTSO in Q1 2021 and held it in 21 quarters. The position peaked at $2K in Q3 2021. 51 funds tracked by Wall St. Rank hold CTSO as of Q2 2026.

Your Advocates Ltd reported no remaining Cytosorbents Corp position as of Q2 2026 after selling out during the quarter.
Your Advocates Ltd sold 250 Cytosorbents Corp shares in Q2 2026, an estimated $143.
Your Advocates Ltd first reported a position in Cytosorbents Corp in Q1 2021 and held it in 21 quarters.
Your Advocates Ltd's Cytosorbents Corp position peaked at $2K in Q3 2021.
51 funds tracked by Wall St. Rank held Cytosorbents Corp as of Q2 2026.

Based on Your Advocates Ltd's 13F filing for Q2 2026, filed 5 Aug 2026.